Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bridgewater, New Jersey 08807


Purpose:

The primary objective of the study is to compare the efficacy of AVE5026 with Enoxaparin for the prevention of Venous Thromboembolic Events (VTE) in patients undergoing hip fracture surgery. The secondary objectives of this study are to evaluate the safety of AVE5026 in patients undergoing hip fracture surgery, and to document AVE5026 exposure in this population.


Study summary:

The total duration of observation per patient is 35 - 42 days from surgery, and includes: - a treatment period of 7 - 10 days, - a follow-up period of 28 - 35 days. Mandatory bilateral venography is performed 7 to 11 days after surgery.


Criteria:

Inclusion Criteria: - Standard surgery for fracture of the upper third of the femur including femoral head and neck. Exclusion Criteria: - Estimated time of injury/fracture > 24 hours before admission to hospital - Any major orthopedic surgery in the 3 months prior to study start - Multiple trauma affecting more than one organ system - Deep vein thrombosis or pulmonary embolism within the last 12 months or known post-phlebitic syndrome - Patients at high risk of bleeding - Known allergy to heparin, or enoxaparin, or pork products The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.


NCT ID:

NCT00721760


Primary Contact:

Principal Investigator
William D. Fisher, MD
Department of Orthopaedic Surgery, McGill University Health Centre, 1650 Cedar Avenue, Montreal, Que


Backup Contact:

N/A


Location Contact:

Bridgewater, New Jersey 08807
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.